Novavax Medical Information

DISCLAIMER: THIS PAGE IS INTENDED FOR HEALTHCARE PROFESSIONALS IN Poland ONLY.

If you are NOT a Healthcare Professional in Poland, please switch to the Consumer Medical Information page.

Information on the NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601)

If your enquiry is regarding the NuvaxovidTM XBB.1.5▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601), you can find some useful information in the resources below.

Request Medical Information

Healthcare Professionals may request medical information via ONE of the following ways:

Option 1: Complete and submit a Medical Information Request Form by clicking on the button below.

Request Medical Information

Option 2: Call +48 22 104 74 91 between 09:00–17:00.

Report an Adverse Event (AE)

If you are concerned about an adverse event, it should be reported to the Office for Medicinal Products, Medical Devices and Biocides at http://www.urpl.gov.pl.

Alternatively, adverse events of concern in association with a Novavax product can be reported to Novavax Pharmacovigilance at +48 22 104 74 91 or via the Novavax Adverse Event Reporting Form.

Report a Product Quality Complaint

If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please call +48 22 104 74 91 between 09:00–17:00.